Taiwan FDA registration 7541c691f79e25e53533f90c5a976be7
"Weibao" Prismavrex Continuous Fluid Management and Renal Replacement Therapy Integrated System
TW: "衛寶" 普利司馬弗列克斯連續液體管理及腎臟替代治療整合系統
Taiwan·GAMBRO LUNDIA AB·Registered Aug 04, 2005 – Aug 04, 2015CancelledRegistration details
- Analysis ID
- 7541c691f79e25e53533f90c5a976be7
- Customs Code
- DHA00601165201
Company information
- Manufacturer
- GAMBRO LUNDIA AB
- Manufacturer Country
- Sweden
- Authorized Representative
- BAXTER HEALTHCARE LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology and urology
- Import Information
- import
Dates and status
- Registration Date
- Aug 04, 2005
- Expiry Date
- Aug 04, 2015
- Cancellation Date
- Oct 08, 2015
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Weibao" Prismavrex Continuous Fluid Management and Renal Replacement Therapy Integrated System in Taiwan's medical device market through Pure Global AI's free database. is registered under number 7541c691f79e25e53533f90c5a976be7 and manufactured by GAMBRO LUNDIA AB. The authorized representative in Taiwan is BAXTER HEALTHCARE LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices